Changes of Functional Connectivity, Reho and ALFF after acupunctured Zusanli point tested by Resting-state functional magnetic resonance imaging

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TCC-09000516

Enrollment

Unknown

Registered

2009-08-27

Start date

2008-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Gastritis and Stroke

Interventions

normal group:acupunctureat Zusanli point

Stroke group:acupunctureat Zusanli point

Chronic gastritis group:acupunctureat Zusanli point

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Normal group: 1. Healthy; No case history of psychoneural system; No physical and mental symptom in the near future of experiment, such as pain or depression and so on; 2. Between the age from 30 to 65 years old; 3. Right handedness; 4. The subjects who have already signed the informed consent. Chronic gastritis group: 1. Healthy; No case history of psychoneural system; No physical and mental symptom in the near future of experiment,such as pain or depression and so on; 2. Between the age from 30 to 65 years old; 3. Right handedness; 4. Gastric tumor was exclude by gastroscope; 5. The patient with typical functional stomach illness symptom; 6. The subjects who have already signed the informed consent. Stroke group: 1. Healthy; No case history of psychoneural system; No physical and mental symptom in the near future of experiment, such as pain or depression and so on; 2. Aged from 30 to 65 years old; 3. Right handedness; 4. The patient more than 3 months after first stroke; 5. The subjects who have already signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. No serious visual disorder and hearing disturbance; 2. History of metal in the body or operation; 3. The women who were in the process of menses or pregnancy; 4. History of serious primary diseases of hepatic, renal, hematopoietic and endocrine system, or psychosis, diabetes mellitus, or having taken excessive alcohol or abused medicines; or malignant tumor; 5. History of having taken sedative within one week before experiment.

Design outcomes

Primary

Measure	Time frame
Regional homogeneity;Functional Connectivity;Amplitude of low-frequency fluctuation;	—

Countries

China

Contacts

Public ContactYu Long

jackyulong@163.com+86 020 81887233-38112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026